Cell-based assays are laboratory techniques that use living cells to measure biological responses, evaluate drug activity, assess toxicity, and investigate disease mechanisms. In North America, particularly the United States and Canada, cell-based assays are widely used in pharmaceutical research, biotechnology, academic institutions, and clinical laboratories to support drug discovery, biologics development, and precision medicine.
Cell-based assays are laboratory techniques that use living cells to study biological processes, evaluate drug activity, assess toxicity, and support the development of pharmaceuticals, biologics, and advanced therapies. In Europe, cell-based assays are a major component of drug discovery, biotechnology research, regenerative medicine, immunotherapy development, and safety testing.
Cell-based assays are laboratory tests that use living cells to evaluate the biological activity, efficacy, toxicity, or mechanism of action of drugs, biologics, vaccines, and other compounds. In the Asia-Pacific (APAC) region, these assays are increasingly important in pharmaceutical research, biotechnology, academic research, and drug development due to expanding investments in life sciences and precision medicine.
Antimicrobial Susceptibility Testing (AST) in the Asia-Pacific (APAC) region is a laboratory procedure used to determine whether bacteria or fungi are susceptible or resistant to antimicrobial agents. AST is essential for selecting appropriate treatment, monitoring antimicrobial resistance (AMR), and supporting antimicrobial stewardship across hospitals, public health laboratories, and research institutions.
